0000874015-20-000152.txt : 20201125 0000874015-20-000152.hdr.sgml : 20201125 20201125190419 ACCESSION NUMBER: 0000874015-20-000152 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201123 FILED AS OF DATE: 20201125 DATE AS OF CHANGE: 20201125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROOKE STANLEY T CENTRAL INDEX KEY: 0000897667 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 201352416 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-11-23 0000874015 IONIS PHARMACEUTICALS INC IONS 0000897667 CROOKE STANLEY T C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD, CA 92010 1 1 0 0 Exec Chairman of the Board Common Stock 2020-11-23 2020-11-23 4 M 0 500 39.87 A 2081 I by wife Common Stock 2020-11-23 2020-11-23 4 S 0 500 50 D 1581 I by wife Common Stock 2020-11-23 2020-11-23 4 M 0 11600 39.87 A 13621 D Common Stock 2020-11-23 2020-11-23 4 S 0 11600 50.11 D 2021 D Common Stock 2020-11-24 2020-11-24 4 M 0 2590 39.87 A 4611 D Common Stock 2020-11-24 2020-11-24 4 S 0 2590 50.83 D 2021 D Common Stock 650391 I by Trust Non-Qualified Stock Option (right to buy) 39.87 2020-11-23 2020-11-23 4 M 0 500.0 0.0 D 2015-01-02 2021-01-01 Common Stock 0 0 I by wife Non-Qualified Stock Option (right to buy) 39.87 2020-11-23 2020-11-23 4 M 0 11600.0 0.0 D 2015-01-02 2021-01-01 Common Stock 0.0 15580.0 D Non-Qualified Stock Option (right to buy) 39.87 2020-11-24 2020-11-24 4 M 0 2590 0 D 2015-01-02 2021-01-01 Common Stock 0 12990 D Acquired as a result of exercising a stock option that was scheduled to expire on 1/1/21. The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person's wife on March 13, 2019. Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person's wife on March 13, 2019. Acquired as a result of exercising a stock option that was scheduled to expire on 1/1/21. The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 13, 2019. Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 13, 2019. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.25, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) of this Form 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.50 to $51.00, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) of this Form 4. /s/Patrick R. O'Neil, attorney-in-fact 2020-11-25